Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

PDRN helps repair tissue and improve wound healing with a high safety profile.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Pharmacists play a crucial role in customizing treatments and ensuring medication safety.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Doxorubicin causes heart damage, so early detection and monitoring are important during chemotherapy.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Ondansetron can cause serious allergic reactions, so use it carefully.

A new compound was effective for imaging prostate cancer in rats.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Combining dexmedetomidine and ketamine provides better sedation and pain relief than dexmedetomidine alone.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

RC48 shows promise for treating certain advanced cancers, but more research is needed.